S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Stock market today: Asian shares mixed as Japan business confidence rises and US shutdown is averted
Is NVIDIA Leading a "Magnificent Seven Bubble"? (Ad)
Federal student loan payments are starting again. Here's what you need to know
Bank of Japan survey shows manufacturers optimistic about economy
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Facing increasing pressure from customers, some miners are switching to renewable energy
Grant program for Black women entrepreneurs blocked by federal appeals court
BREAKING: Tiny biotech successfully treats blindness (Ad)
The death toll in a collapsed gold mine in Zimbabwe expected to rise to 13, vice president says
The UAE holds an annual oil and gas conference just ahead of hosting UN COP28 climate talks in Dubai
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Stock market today: Asian shares mixed as Japan business confidence rises and US shutdown is averted
Is NVIDIA Leading a "Magnificent Seven Bubble"? (Ad)
Federal student loan payments are starting again. Here's what you need to know
Bank of Japan survey shows manufacturers optimistic about economy
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Facing increasing pressure from customers, some miners are switching to renewable energy
Grant program for Black women entrepreneurs blocked by federal appeals court
BREAKING: Tiny biotech successfully treats blindness (Ad)
The death toll in a collapsed gold mine in Zimbabwe expected to rise to 13, vice president says
The UAE holds an annual oil and gas conference just ahead of hosting UN COP28 climate talks in Dubai
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Stock market today: Asian shares mixed as Japan business confidence rises and US shutdown is averted
Is NVIDIA Leading a "Magnificent Seven Bubble"? (Ad)
Federal student loan payments are starting again. Here's what you need to know
Bank of Japan survey shows manufacturers optimistic about economy
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Facing increasing pressure from customers, some miners are switching to renewable energy
Grant program for Black women entrepreneurs blocked by federal appeals court
BREAKING: Tiny biotech successfully treats blindness (Ad)
The death toll in a collapsed gold mine in Zimbabwe expected to rise to 13, vice president says
The UAE holds an annual oil and gas conference just ahead of hosting UN COP28 climate talks in Dubai
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Stock market today: Asian shares mixed as Japan business confidence rises and US shutdown is averted
Is NVIDIA Leading a "Magnificent Seven Bubble"? (Ad)
Federal student loan payments are starting again. Here's what you need to know
Bank of Japan survey shows manufacturers optimistic about economy
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Facing increasing pressure from customers, some miners are switching to renewable energy
Grant program for Black women entrepreneurs blocked by federal appeals court
BREAKING: Tiny biotech successfully treats blindness (Ad)
The death toll in a collapsed gold mine in Zimbabwe expected to rise to 13, vice president says
The UAE holds an annual oil and gas conference just ahead of hosting UN COP28 climate talks in Dubai
NYSEAMERICAN:INFU

InfuSystem (INFU) Stock Forecast, Price & News

$9.64
-0.20 (-2.03%)
(As of 09/29/2023 08:53 PM ET)
Compare
Today's Range
$9.59
$9.93
50-Day Range
N/A
52-Week Range
$6.10
$11.44
Volume
32,000 shs
Average Volume
61,611 shs
Market Capitalization
$203.02 million
P/E Ratio
321.44
Dividend Yield
N/A
Price Target
N/A

InfuSystem MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
1.61% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.20
Upright™ Environmental Score
News Sentiment
0.84mentions of InfuSystem in the last 14 days
Based on 2 Articles This Week
Insider Trading
Selling Shares
$864,215 Sold Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.00 out of 5 stars


INFU stock logo

About InfuSystem (NYSEAMERICAN:INFU) Stock

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.

INFU Price History

INFU Stock News Headlines

Lake Street Keeps Their Buy Rating on Accuray (ARAY)
Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video)
“Hi, I’m Teeka Tiwari...I’m about to get in this Tesla and drive up to a facility just a few miles from here to show you what could be the secret behind Elon Musk’s new AI project… What happens next will shock you…”
Q2 2023 Sanara Medtech Inc Earnings Call
Better Than Oil Stocks
The best way to profit from energy is NOT a stock...Rather, it's this little-known alternative investment. 
See More Headlines
Receive INFU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for InfuSystem and its competitors with MarketBeat's FREE daily newsletter.

INFU Company Calendar

Last Earnings
8/03/2023
Today
10/01/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NYSEAMERICAN:INFU
Employees
420
Year Founded
N/A

Profitability

Net Income
$20,000.00
Pretax Margin
0.93%

Debt

Sales & Book Value

Annual Sales
$109.91 million
Cash Flow
$0.65 per share
Book Value
$2.32 per share

Miscellaneous

Free Float
17,160,000
Market Cap
$203.02 million
Optionable
Not Optionable
Beta
1.25
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

  • Mr. Richard A. DiIorio (Age 48)
    CEO & Director
    Comp: $806.26k
  • Ms. Carrie A. Lachance B.S.N. (Age 46)
    M.B.A., R.N., Pres, COO & Director
    Comp: $473.54k
  • Mr. Barry G. Steele (Age 52)
    Exec. VP & CFO
  • Mr. Addam Chupa (Age 44)
    Exec. VP & Chief Information Officer
  • Jeanie Latz
    Corp. Sec.













INFU Stock - Frequently Asked Questions

How have INFU shares performed in 2023?

InfuSystem's stock was trading at $9.30 at the start of the year. Since then, INFU shares have increased by 3.7% and is now trading at $9.64.
View the best growth stocks for 2023 here
.

Are investors shorting InfuSystem?

InfuSystem saw a decline in short interest in September. As of September 15th, there was short interest totaling 296,600 shares, a decline of 15.2% from the August 31st total of 349,600 shares. Based on an average daily volume of 50,800 shares, the days-to-cover ratio is currently 5.8 days. Currently, 1.6% of the shares of the stock are short sold.
View InfuSystem's Short Interest
.

How were InfuSystem's earnings last quarter?

InfuSystem Holdings, Inc. (NYSEAMERICAN:INFU) issued its earnings results on Thursday, August, 3rd. The medical instruments supplier reported $0.02 EPS for the quarter. The medical instruments supplier had revenue of $31.74 million for the quarter. InfuSystem had a trailing twelve-month return on equity of 1.36% and a net margin of 0.56%.

What guidance has InfuSystem issued on next quarter's earnings?

InfuSystem updated its FY 2023 earnings guidance on Thursday, August, 3rd. The company provided EPS guidance of for the period. The company issued revenue guidance of $120.91M-, compared to the consensus revenue estimate of $120.00 million.

What other stocks do shareholders of InfuSystem own?

Based on aggregate information from My MarketBeat watchlists, some companies that other InfuSystem investors own include Macquarie Infrastructure (MIC), Second Sight Medical Products (EYES), Otelco (OTEL), Pershing Gold (PGLC), Palatin Technologies (PTN), AgroFresh Solutions (AGFS), Advanced Micro Devices (AMD) and Digital Turbine (APPS).

What is InfuSystem's stock symbol?

InfuSystem trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "INFU."

How do I buy shares of InfuSystem?

Shares of INFU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is InfuSystem's stock price today?

One share of INFU stock can currently be purchased for approximately $9.64.

How much money does InfuSystem make?

InfuSystem (NYSEAMERICAN:INFU) has a market capitalization of $203.02 million and generates $109.91 million in revenue each year. The medical instruments supplier earns $20,000.00 in net income (profit) each year or $0.03 on an earnings per share basis.

How many employees does InfuSystem have?

The company employs 420 workers across the globe.

How can I contact InfuSystem?

InfuSystem's mailing address is 31700 Research Park Dr, MADISON HEIGHTS, MI 48071-4627, United States. The official website for the company is ir.infusystem.com. The medical instruments supplier can be reached via phone at (124) 291-1210 or via fax at 800-455-4338.

This page (NYSEAMERICAN:INFU) was last updated on 10/2/2023 by MarketBeat.com Staff

My Account -